Stern IR News and Events

Beat on the Street: May 7, 2021

Defining “The Good Crossover” Financing; GameStop Blowback; A New Index in Town?; Market Updates

Beat on the Street: April 23, 2021

1Q financing roundup; Rapid expansion of the biotech sector; Market update

Beat on the Street: April 9, 2021

Increasing SEC Enforcement Focus on SPACs; Gender Diversity in Company Creation; Weekly Market Update

Beat on the Street: March 26, 2021

Predicting the Future: Cowen Analyzes Biotech Performance in Higher Interest Rate Environments; FTC Crackdown on Pharma Mergers; Biotech Capital Flow and Market Updates

Beat on the Street: March 19, 2021

Congratulations to SternIR clients on recent NDA acceptances; recent SEC crackdowns; Cowen: The latest player in ESG; Investor Relations is a competitive advantage.

Beat on the Street: March 5, 2021

Top Biotech CEOs of 2021; This week in ESG; Biopharma Venture Investing Boom

Beat on the Street: February 19, 2021

The drumbeat for ESG initiatives is only growing louder.

Beat on the Street: February 5, 2021

Our take on the short squeeze, VC funding, and biotech financing

Beat on the Street: January 29, 2021

Preparing for Proxy Season; Planning for Virtual Annual Meetings; Market Update

Beat on the Street: January 22, 2021

BioCentury’s Look Ahead to 2021; Another Alternative to IPOs?; Vanguard and ESG

Beat on the Street: Year in Review: December 22, 2020

SternIR's look back on 2020.

J.P. Morgan 2021 Health Conference: January 11-14, 2021

Schedule a virtual 1x1 meeting with 75+ of our top-tier companies during the week of the Virtual J.P. Morgan Healthcare Conference, to be held on January 11 – 14, 2021.

Beat on the Street: December 4, 2020

Despite the holiday “break,” it’s been a very busy few weeks for Stern IR clients and we wanted to congratulate several on recent clinical, regulatory and corporate successes:

Beat on the Street: November 20, 2020

We hope you are all looking forward to some well-earned R&R over the Thanksgiving holiday – it’s been a wild few weeks for biotech!

Precision Medicine Group Secures Major Investment from Blackstone: November 20, 2020

Stern Investor Relations parent company, Precision Medicine Group, announced that it has completed a major investment and recapitalization led by funds managed by Blackstone, with significant participation from Precision’s co-founders, as well as current shareholders Berkshire Partners, TPG Growth, Oak HC/FT and Vida Ventures.

Beat on the Street: November 13, 2020

Let us begin by congratulating Stern IR client Gilead, who ranked highly in this year’s II awards across several metrics, including best investor relations program, best CEO and CFO, and best communication of strategy and risk management amid COVID-19. Go GILD!

Beat on the Street: October 30, 2020

We want to start by congratulating several Stern IR clients on major accomplishments, all from this week alone! We also have a 13F update, even more SPACs, and a market update.

Beat on the Street: October 19, 2020

#JPMorgan2021 – It’s Here!

Beat on the Street: October 2, 2020

Congratulating Stern IR clients, Atea Pharmaceuticals and Goldfinch Bio, who were named among Fierce Biotech’s 2020 Fierce 15, and Tmunity Therapeutics, who was named to the Endpoints 11!

Beat on the Street: September 28, 2020

Back to school and back to business, NASDAQ responds to the SEC’s proposed amendments to the 13F reporting threshold, and a market update.